The topoisomerases of protozoan parasites

Parasitology Today

Volumn 16, Issue 7, 2000, Pages 277-281

  Cheesman, S J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE DERIVATIVE; ANTIMALARIAL AGENT; ANTIPROTOZOAL AGENT; CIPROFLOXACIN; DIMINAZENE ACETURATE; DNA TOPOISOMERASE; DNA TOPOISOMERASE INHIBITOR; PYRONARIDINE; STIBOGLUCONATE SODIUM;

ANTIMALARIAL ACTIVITY; ANTIPROTOZOAL ACTIVITY; DRUG TARGETING; ENZYME ACTIVITY; GENE EXPRESSION; NONHUMAN; PLASMODIUM; PROTOZOON; REVIEW;

ANIMALS; DNA TOPOISOMERASES, TYPE I; HUMANS; PROTOZOA; PROTOZOAN INFECTIONS;

BACTERIA (MICROORGANISMS); PROTOZOA;

EID: 0034234657     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-4758(00)01697-5     Document Type: Review

References (47)

1. Champoux J.J. Domains of human topoisomerase I and associated functions. Prog. Nucleic Acids Res. Mol. Biol. 60:1998;111-132.
2. Tosh K., Kilbey B. The gene encoding topoisomerase I from the human malarial parasite Plasmodium falciparum. Gene. 163:1995;151-154.
3. Broccoli S.et al. Characterisation of a Leishmania donovani gene encoding a protein that closely resembles a type IB topoisomerase. Nucleic Acids Res. 27:1999;2745-2752.
4. Strauss P.R., Wang J.C. The TOP2 gene of Trypanosoma brucei - a single-copy gene that shares extensive homology with other TOP2 genes encoding eukaryotic DNA topoisomerase II. Mol. Biochem. Parasitol. 38:1990;141-150.
5. Fragoso S.P., Goldenberg S. Cloning and characterisation of the gene encoding Trypanosoma-cruzi DNA topoisomerase II. Mol. Biochem. Parasitol. 55:1992;127-134.
6. Cheesman S.et al. The gene encoding topoisomerase II from Plasmodium falciparum. Nucleic Acids Res. 22:1994;2547-2551.
7. Christopher L.J., Dykstra C.C. Identification of a type II topoisomerase gene from Cryptosporidium parvum. J. Euk. Microbiol. 41:1994;28S.
8. Ridley R.G. Proteins of unusual sequence composition from the malarial parasite Plasmodium falciparum. Biochem. Soc. Trans. 19:1991;525-528.
9. Isaacs R.J.et al. Physiological regulation of eukaryotic topoisomerase II. Biochim. Biophys. Acta. 1400:1998;121-137.
10. Pommier Y.et al. Mechanisms of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme. Biochim. Biophys. Acta. 1400:1998;83-106.
11. Pasion S.G.et al. Sequences within the 5′ untranslated region regulate the levels of a kinetoplast DNA topoisomerase mRNA during the cell cycle. Mol. Biochem. Parasitol. 16:1996;6724-6735.
12. Mahmood R., Ray D.S. Nuclear extracts of Crithidia fasciculata contain a factor(s) that binds to the 59 untranslated regions of TOP2 and RPAI mRNA's containing sequences required for their cell cycle regulation. J. Biol. Chem. 273:1998;23729-23734.
13. Cheesman S.et al. Intraerythrocytic expression of topoisomerase II from Plasmodium falciparum is developmentally regulated. Mol. Biochem. Parasitol. 92:1998;39-46.
14. Tosh K.et al. Plasmodium falciparum: stage-related expression of topoisomerase I. Exp. Parasitol. 91:1999;126-132.
15. Fragoso S.P.et al. Expression and cellular localisation of Trypanosoma cruzi type II DNA topoisomerase. Mol. Biochem. Parasitol. 94:1998;197-204.
16. Heller R.A.et al. Multiple forms and cellular localisation of Drosophila DNA topoisomerase II. J. Biol. Chem. 261:1986;8063-8069.
17. Chakraborty A.K., Majumder H.K. Mode of action of pentavalent antimonials: specific inhibition of type I DNA topoisomerase of Leishmania donovani. Biochem. Biophys. Res. Commun. 152:1988;605-611.
18. Chakraborty A.et al. A type I DNA topoisomerase from the kinetoplast hemoflagellate Leishmania donovani. Indian J. Biochem. Biophys. 30:1993;257-263.
19. Riou G.et al. A type I topoisomerase from Trypanosoma cruzi. Eur. J. Biochem. 134:1983;479-484.
20. Riou J-F.et al. Purification and characterisation of Plasmodium bergei DNA topoisomerases I and II: drug action, inhibition of decatenation and relaxation, and stimulation of DNA cleavage. Biochemistry. 25:1986;1473-1479.
21. Chavalitshewinkoon P.et al. Partial purification and characterisation of DNA topoisomerase II from Plasmodium falciparum. Southeast Asian J. Trop. Med. Public Health. 25:1994;32-36.
22. Chakraborty A.K., Majumder H.K. Decatenation of kinetoplast DNA by an ATP-dependent DNA topoisomerase from the kinetoplast hemoflagellate Leishmania donovani. Mol. Biochem. Parasitol. 26:1987;215-224.
23. Chakraborty A.K., Mujumder H.K. An ATP-independent catenating enzyme from the kinetoplast hemoflagellate Leishmania donovani. Biochem. Biophys. Res. Commun. 180:1991;279-285.
24. Bell C.et al. Structure-activity studies of dicationically substituted bis-benzimidazoles against Giardia lamblia: correlation of antigiardial activity with DNA binding affinity and giardial topoisomerase II inhibition. Antimicrob. Agents Chemother. 37:1993;2668-2673.
25. Douc-Rasy S.et al. ATP independent type II topoisomerase from trypanosomes. Proc. Natl. Acad. Sci. U. S. A. 83:1986;7152-7156.
26. Sinha B.K. Topoisomerase inhibitors. Drugs. 49:1996;11-19.
27. Cain B.F., Atwell G.J. The experimental antitumor properties of three congeners of the acridylmethanesulphonanilide (AMSA) series. Eur. J. Cancer. 10:1974;539-549.
28. Ringwald P.et al. Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa. Lancet. 347:1996;24-28.
29. Looareesuwan S.et al. Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum malaria in Thailand. Am. J. Trop. Med. Hyg. 54:1996;205-209.
30. Werbovetz K.A.et al. Cleavable complex formation in Leishmania chagasi treated with anilinoacridines. Mol. Biochem. Parasitol. 65:1994;1-10.
31. Mesa-Valle C.M.et al. Activity and mode of action of acridine compounds against Leishmania donovani. Antimicrob. Agents Chemother. 40:1996;684-690.
32. Chavalitshewinkoon P.et al. Structure-activity relationships and modes of action of 9-anilinoacridines against chloroquine-resistant Plasmodium falciparum in vitro. Antimicrob. Agents Chemother. 37:1993;403-406.
33. Gamage S.et al. Synthesis and in vitro evaluation of 9-anilino-3,6,-diaminoacridines active against a multidrug-resistant strain of the malaria parasite Plasmodium falciparum. J. Med. Chem. 37:1994;1486-1494.
34. Kawai S.et al. The effects of pyronaridine on the morphology of Plasmodium falciparum in Aotus trivirgatus. Am. J. Trop. Med. Hyg. 55:1996;223-229.
35. Weissig V.et al. Topoisomerase II inhibitors induce cleavage of nuclear and 35-kb plastid DNAs in the malarial parasite Plasmodium falciparum. DNA Cell. Biol. 16:1997;1483-1492.
36. Shapiro T.A. Inhibition of topoisomerases in African trypanosomes. Acta Trop. 54:1993;251-260.
37. Shapiro T.et al. Drug-promoted cleavage of kinetoplast DNA minicircles. J. Biol. Chem. 264:1989;4173-4178.
38. Shapiro T.A., Showalter A.F. In vivo inhibition of trypanosome mitochondrial topoisomerase II: effects on kinetoplast DNA maxicircles. Mol. Cell. Biol. 14:1994;5891-5897.
39. Shapiro T.A., Englund P.T. Selective cleavage of kinetoplast minicircles promoted by antitrypanosomal drugs. Proc. Natl. Acad. Sci. U. S. A. 87:1990;950-954.
40. Pilch D.S.et al. Berenil [1,3-bis (4′-amidinophenyl)triazene] binding to DNA duplexes and to a RNA duplex. evidence for both intercalative and minor groove binding properties Biochemistry. 34:1995;9962-9976.
41. Bodley A.L., Shapiro T.A. Molecular and cytotoxic effects of camptothecin, a topoisomerase I inhibitor, on trypanosomes and Leishmania. Proc. Natl. Acad. Sci. U. S. A. 92:1995;3726-3730.
42. Bodley A.L.et al. Antitrypanosomal sensitivity of camptothecin analogs. Biochem. Pharmacol. 50:1995;937-942.
43. Bodley A.et al. Effects of camptothecin, a topoisomerase I inhibitor, on Plasmodium falciparum. Biochem. Pharmacol. 55:1998;709-711.
44. Ray S.et al. Diospyrin, a bisnaphthoquinone: a novel inhibitor of type I DNA topoisomerase of Leishmania donovani. Mol. Pharmacol. 54:1998;994-999.
45. Wigley D.B.et al. Crystal structure of an N-terminal fragment of the DNA gyrase B protein. Nature. 351:1991;624-629.
46. Morais Cabral J.H.et al. Crystal structure of the breakage-reunion domain of DNA gyrase. Nature. 388:1997;903-906.
47. Berger J.M.et al. Structure and mechanism of DNA topoisomerase II. Nature. 379:1996;225-232.